ChemicalBook--->CAS DataBase List--->1152311-62-0

1152311-62-0

1152311-62-0 Structure

1152311-62-0 Structure
IdentificationBack Directory
[Name]

VX-661
[CAS]

1152311-62-0
[Synonyms]

VX-661
CS-956
VX-661/VX661
VX661/Tezacaftor
VX-661 USP/EP/BP
tezacaftor(VX661)
VX 661; VX661;VX-661
VX 661;VX661;VX-661; TEZACAFTOR
(R)-1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-
1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)indol-5-yl]cyclopropane-1-carboxamide
1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-cyclopropanecarboxamide
Cyclopropanecarboxamide, 1-(2,2-difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-
(R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-Methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxaMide
1-(2,2-Difluoro-1,3-benzodioxol-5-yl)-N-[1-[(2R)-2,3-dihydroxypropyl]-6-fluoro-2-(2-hydroxy-1,1-dimethylethyl)-1H-indol-5-yl]-cyclopropanecarboxamide VX661
[Molecular Formula]

C26H27F3N2O6
[MDL Number]

MFCD23106064
[MOL File]

1152311-62-0.mol
[Molecular Weight]

520.5
Chemical PropertiesBack Directory
[Boiling point ]

610.8±55.0 °C(Predicted)
[density ]

1.49±0.1 g/cm3(Predicted)
[storage temp. ]

Store at -20°C , stored under nitrogen
[solubility ]

≥21.8 mg/mL in DMSO; insoluble in EtOH; ≥24.3 mg/mL in H2O
[form ]

solid
[pka]

13.99±0.20(Predicted)
[color ]

White to yellow
[InChIKey]

MJUVRTYWUMPBTR-MRXNPFEDSA-N
[SMILES]

C1(C2=CC=C3OC(F)(F)OC3=C2)(C(NC2C(F)=CC3=C(C=2)C=C(C(C)(C)CO)N3C[C@@H](O)CO)=O)CC1
Hazard InformationBack Directory
[Description]

Tezacaftor (VX-661) is an oral medication for cystic fibrosis (CF) developed by Vertex Pharmaceuticals. In a combination therapy formulation called Symdeko (tezacaftor plus ivacaftor), it is approved in the U.S. and Canada for CF patients, ages 12 and older, who have two copies of the F508del mutation in the CFTR gene and one minimal function mutation. Symdeko is approved and marketed in the EU as Symkevi.Tezacaftor is not approved as a stand-alone treatment, but as part of a combination therapy.
[Uses]

Tezacaftor is used as a combination therapy with Ivacaftor for the treatment of patients with cystic fibrosis.
[Definition]

VX-661 is an investigational compound that promotes the maturation of delta F508 mutants of the cystic fibrosis transmembrane conductance regulator (CFTR). Delta F508 CFTR represents a class of CFTR mutation that is characterized by impaired processing of misfolded CFTR proteins and reduced accumulation of the protein at the cell surface. VX-661 is intended to facilitate trafficking of CFTR to the epithelial cell membrane. It may be combined with the CFTR potentiator ivacaftor (Item No. 15145) to stimulate both CFTR accumulation and opening at the apical epithelial surface.
[Indications]

Tezacaftor is combined with ivacaftor in one product for the treatment of cystic fibrosis (CF) in patients aged 12 years or older with two copies of the F508del gene mutation or at least one mutation in the CFTR gene that is responsive to this drug.
Tezacaftor, when used in combination with ivacaftor and elexacaftor in the product Trikafta, is also indicated for the treatment of CF in patients 12 years of age and older that have at least one F508del mutation in the CFTR gene.
[Biochem/physiol Actions]

VX-661 is another cystic fibrosis transmembrane conductance regulator (CFTR) corrector in development for the treatment of cystic fibrosis.
[Mechanism of action]

The transport of charged ions across cell membranes is normally achieved through the actions of the cystic fibrosis transmembrane regulator (CFTR) protein. This protein acts as a channel and allows for the passage of chloride and sodium. This process affects the movement of water in and out of the tissues. It impacts the production of mucus that lubricates and protects certain organs and body tissues, including the lungs. In the F508del mutation of the CFTR gene, one amino acid is deleted at position 508. Therefore, the CFTR channel function is compromised, resulting in thickened mucus secretions. CFTR correctors such as tezacaftor aim to repair F508del cellular misprocessing. This is done by modulating the position of the CFTR protein on the cell surface to the correct position, allowing for adequate ion channel formation and increased water and salt movement through the cell membrane. The concomitant use of ivacaftor is intended to maintain an open channel, increasing the transport of chloride and reducing thick mucus production.
[in vitro]

VX-661, is CFTR modulator that is potentially useful for treatment of cystic fibrosis. VX-661 corrects F508del-CFTR trafficking and increases F508del-CFTR protein activity in vitro.
[target]

F508 del CFTR
[storage]

Store at -20°C , stored under nitrogen
[References]

[1] s. donaldson, j. pilewski, m. griese, q. dong, p.-s. lee, for the vx11–661-101 study group. ws7.3 vx-661, an investigational cftr corrector, in combination with ivacaftor, a cftr potentiator, in patients with cf and homozygous for the f508del-cftr mutation: interim analysis. journal of cystic fibrosis, volume 12, supplement 1, june 2013, page s14
Spectrum DetailBack Directory
[Spectrum Detail]

VX-661(1152311-62-0)1HNMR
1152311-62-0 suppliers list
Company Name: Shijiazhuang Dingmin Pharmaceutical Sciences Co., Ltd.
Tel: +86-0311-67591193 +8613931880626 , +8613931880626
Website: www.dingminpharmaceutical.com
Company Name: Hangzhou FandaChem Co.,Ltd.
Tel: 008657128800458; +8615858145714 , +8615858145714
Website: http://www.fandachem.com
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695 , +8613203830695
Website: www.coreychem.com/
Company Name: Biochempartner
Tel: 0086-13720134139
Website: www.biochempartner.com
Company Name: BOC Sciences
Tel: +1-631-485-4226
Website: www.bocsci.com/
Company Name: Chongqing Chemdad Co., Ltd
Tel: +86-023-6139-8061 +86-86-13650506873 , +86-86-13650506873
Website: http://www.chemdad.com/
Company Name: ENBRIDGE PHARMTECH CO., LTD.
Tel: +8613812269233 , +8613812269233
Website: https://www.chemicalbook.com/manufacturer/enbridge-pharmtech-240/
Company Name: Zhengzhou Alfa Chemical Co.,Ltd
Tel: +8618530059196 , +8618530059196
Website: https://www.chemicalbook.com/manufacturer/zhengzhou-alfa-chemical-276/
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: Allfluoro pharmaceutical co. ltd.
Tel: 021-26137118 +8615821363818 , +8615821363818
Website: https://www.allfluoro.com
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226 , 13588875226
Website: www.hzclap.com/en
Company Name: Qiuxian Baitai New Material Co., LTD
Tel: +8618330912755 , +8618330912755
Website: https://www.chemicalbook.com/manufacturer/qiuxian-baitai-new-material-384/
Company Name: Dideu Industries Group Limited
Tel: +86-29-89586680 +86-15129568250 , +86-15129568250
Website: https://www.dideu.com
Company Name: AFINE CHEMICALS LIMITED
Tel: +86-0571-85134551
Website: www.afinechem.com/index.html
Company Name: Wuhan Nutra Biotechnology Co.,Ltd
Tel: +8617786394783 , +8617786394783
Website: www.nutrabiotechchem.com/
Company Name: Senova Technology Co. Ltd.
Tel: +86-0755-86703119 +8618503098836 , +8618503098836
Website: www.senovatech.com/
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105 , +1-13798911105
Website: https://www.invivochem.com/
Company Name: Hefei TNJ Chemical Industry Co.,Ltd.
Tel: +86-0551-65418684 +8618949823763 , +8618949823763
Website: www.tnjchem.com
Tags:1152311-62-0 Related Product Information
273404-37-8 50-32-8 95-15-8 132-65-0 209410-46-8 1476074-39-1 1026785-59-0 896720-20-0 745833-23-2 918505-84-7 852808-04-9 873054-44-5 936727-05-8 307510-92-5 775304-57-9